Regulatory uncertainty and the associated business risk for emerging technologies View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-04

AUTHORS

Robert A. Hoerr

ABSTRACT

An oversight system specifically concerned with nanomaterials should be flexible enough to take into account the unique aspects of individual novel materials and the settings in which they might be used, while recognizing that heretofore unrecognized safety issues may require future modifications. This article considers a question not explicitly considered by the project team: what is the risk that uncertainty over how regulatory oversight will be applied to nanomaterials will delay or block the development of this emerging technology, thereby depriving human health of potential and substantial benefits? An ambiguous regulatory environment could delay the availability of valuable new technology and therapeutics for human health by reducing access to investment capital. Venture capitalists list regulatory uncertainty as a major reason not to invest at all in certain areas. Uncertainty is far more difficult to evaluate than risk, which lends itself to quantitative models and can be factored into projections of return on possible investments. Loss of time has a large impact on investment return. An examination of regulatory case histories suggests that an increase in regulatory resting requirement, where the path is well-defined, is far less costly than a delay of a year or more in achieving product approval and market launch. More... »

PAGES

1513-1520

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11051-011-0260-z

DOI

http://dx.doi.org/10.1007/s11051-011-0260-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029510278


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nanocopoeia (United States)", 
          "id": "https://www.grid.ac/institutes/grid.436791.e", 
          "name": [
            "Nanocopoeia, Inc., 1246\u00a0University Avenue West, Suite 463, 55104, St. Paul, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoerr", 
        "givenName": "Robert A.", 
        "id": "sg:person.01054247120.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054247120.92"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1377/hlthaff.25.2.420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019042543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.qref.2004.05.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031762382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-011-0233-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035628628", 
          "https://doi.org/10.1007/s11051-011-0233-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-0-387-78608-7_1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038770758", 
          "https://doi.org/10.1007/978-0-387-78608-7_1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-0-387-78608-7_1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038770758", 
          "https://doi.org/10.1007/978-0-387-78608-7_1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2009.02187.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053685575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2009.02187.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053685575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1142/s0219091507001136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062990009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1287/mnsc.43.4.422", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064721609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1504/ijtm.2006.009446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067499118"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-04", 
    "datePublishedReg": "2011-04-01", 
    "description": "An oversight system specifically concerned with nanomaterials should be flexible enough to take into account the unique aspects of individual novel materials and the settings in which they might be used, while recognizing that heretofore unrecognized safety issues may require future modifications. This article considers a question not explicitly considered by the project team: what is the risk that uncertainty over how regulatory oversight will be applied to nanomaterials will delay or block the development of this emerging technology, thereby depriving human health of potential and substantial benefits? An ambiguous regulatory environment could delay the availability of valuable new technology and therapeutics for human health by reducing access to investment capital. Venture capitalists list regulatory uncertainty as a major reason not to invest at all in certain areas. Uncertainty is far more difficult to evaluate than risk, which lends itself to quantitative models and can be factored into projections of return on possible investments. Loss of time has a large impact on investment return. An examination of regulatory case histories suggests that an increase in regulatory resting requirement, where the path is well-defined, is far less costly than a delay of a year or more in achieving product approval and market launch.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11051-011-0260-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3067449", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1028317", 
        "issn": [
          "1388-0764", 
          "1572-896X"
        ], 
        "name": "Journal of Nanoparticle Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Regulatory uncertainty and the associated business risk for emerging technologies", 
    "pagination": "1513-1520", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8c95274471b63bfa2f86725531c3fa0366f650c6aa5aa77945eea8604c505180"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11051-011-0260-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029510278"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11051-011-0260-z", 
      "https://app.dimensions.ai/details/publication/pub.1029510278"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11051-011-0260-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11051-011-0260-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11051-011-0260-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11051-011-0260-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11051-011-0260-z'


 

This table displays all metadata directly associated to this object as RDF triples.

89 TRIPLES      21 PREDICATES      35 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11051-011-0260-z schema:about anzsrc-for:14
2 anzsrc-for:1402
3 schema:author N844e01af5ecb42ff8831fa76362638ac
4 schema:citation sg:pub.10.1007/978-0-387-78608-7_1
5 sg:pub.10.1007/s11051-011-0233-2
6 https://doi.org/10.1016/j.qref.2004.05.010
7 https://doi.org/10.1111/j.1365-2796.2009.02187.x
8 https://doi.org/10.1142/s0219091507001136
9 https://doi.org/10.1287/mnsc.43.4.422
10 https://doi.org/10.1377/hlthaff.25.2.420
11 https://doi.org/10.1504/ijtm.2006.009446
12 schema:datePublished 2011-04
13 schema:datePublishedReg 2011-04-01
14 schema:description An oversight system specifically concerned with nanomaterials should be flexible enough to take into account the unique aspects of individual novel materials and the settings in which they might be used, while recognizing that heretofore unrecognized safety issues may require future modifications. This article considers a question not explicitly considered by the project team: what is the risk that uncertainty over how regulatory oversight will be applied to nanomaterials will delay or block the development of this emerging technology, thereby depriving human health of potential and substantial benefits? An ambiguous regulatory environment could delay the availability of valuable new technology and therapeutics for human health by reducing access to investment capital. Venture capitalists list regulatory uncertainty as a major reason not to invest at all in certain areas. Uncertainty is far more difficult to evaluate than risk, which lends itself to quantitative models and can be factored into projections of return on possible investments. Loss of time has a large impact on investment return. An examination of regulatory case histories suggests that an increase in regulatory resting requirement, where the path is well-defined, is far less costly than a delay of a year or more in achieving product approval and market launch.
15 schema:genre research_article
16 schema:inLanguage en
17 schema:isAccessibleForFree false
18 schema:isPartOf N017a0feb4cc34e70aad7914cb31d48af
19 Na677e79e25fc48c7b44024620dd0bbcc
20 sg:journal.1028317
21 schema:name Regulatory uncertainty and the associated business risk for emerging technologies
22 schema:pagination 1513-1520
23 schema:productId N2c5f2cd6f1084b47b1083ca6753ccfc7
24 N868ddd4153a24808ae5cdfb32c11e5ad
25 Nb3a89f3b327e40a5bda69181225fbabd
26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029510278
27 https://doi.org/10.1007/s11051-011-0260-z
28 schema:sdDatePublished 2019-04-11T01:07
29 schema:sdLicense https://scigraph.springernature.com/explorer/license/
30 schema:sdPublisher N48466c19a11540aabf9c4e6a8fc036d5
31 schema:url http://link.springer.com/10.1007%2Fs11051-011-0260-z
32 sgo:license sg:explorer/license/
33 sgo:sdDataset articles
34 rdf:type schema:ScholarlyArticle
35 N017a0feb4cc34e70aad7914cb31d48af schema:issueNumber 4
36 rdf:type schema:PublicationIssue
37 N2c5f2cd6f1084b47b1083ca6753ccfc7 schema:name dimensions_id
38 schema:value pub.1029510278
39 rdf:type schema:PropertyValue
40 N48466c19a11540aabf9c4e6a8fc036d5 schema:name Springer Nature - SN SciGraph project
41 rdf:type schema:Organization
42 N844e01af5ecb42ff8831fa76362638ac rdf:first sg:person.01054247120.92
43 rdf:rest rdf:nil
44 N868ddd4153a24808ae5cdfb32c11e5ad schema:name readcube_id
45 schema:value 8c95274471b63bfa2f86725531c3fa0366f650c6aa5aa77945eea8604c505180
46 rdf:type schema:PropertyValue
47 Na677e79e25fc48c7b44024620dd0bbcc schema:volumeNumber 13
48 rdf:type schema:PublicationVolume
49 Nb3a89f3b327e40a5bda69181225fbabd schema:name doi
50 schema:value 10.1007/s11051-011-0260-z
51 rdf:type schema:PropertyValue
52 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
53 schema:name Economics
54 rdf:type schema:DefinedTerm
55 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
56 schema:name Applied Economics
57 rdf:type schema:DefinedTerm
58 sg:grant.3067449 http://pending.schema.org/fundedItem sg:pub.10.1007/s11051-011-0260-z
59 rdf:type schema:MonetaryGrant
60 sg:journal.1028317 schema:issn 1388-0764
61 1572-896X
62 schema:name Journal of Nanoparticle Research
63 rdf:type schema:Periodical
64 sg:person.01054247120.92 schema:affiliation https://www.grid.ac/institutes/grid.436791.e
65 schema:familyName Hoerr
66 schema:givenName Robert A.
67 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054247120.92
68 rdf:type schema:Person
69 sg:pub.10.1007/978-0-387-78608-7_1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038770758
70 https://doi.org/10.1007/978-0-387-78608-7_1
71 rdf:type schema:CreativeWork
72 sg:pub.10.1007/s11051-011-0233-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035628628
73 https://doi.org/10.1007/s11051-011-0233-2
74 rdf:type schema:CreativeWork
75 https://doi.org/10.1016/j.qref.2004.05.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031762382
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1111/j.1365-2796.2009.02187.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053685575
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1142/s0219091507001136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062990009
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1287/mnsc.43.4.422 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064721609
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1377/hlthaff.25.2.420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019042543
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1504/ijtm.2006.009446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067499118
86 rdf:type schema:CreativeWork
87 https://www.grid.ac/institutes/grid.436791.e schema:alternateName Nanocopoeia (United States)
88 schema:name Nanocopoeia, Inc., 1246 University Avenue West, Suite 463, 55104, St. Paul, MN, USA
89 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...